⌘K
Loading ticker…
Anavex Life Sciences · Healthcare · Pharmaceutical Products
As of 2026-06-26, Anavex Life Sciences (AVXL) has a 3-month relative strength percentile of 27 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 36. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.0%, relative volume 2.76×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
27 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
AVXL is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -11.2% / -45.8%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
AVXL is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $8M notional. Top 3 carry $23M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $8M |
| XBIState Street SPDR S&P Biotech ETF | 0.11% | $8M |
| IWMiShares Russell 2000 ETF | 0.01% | $7M |
| VXFVanguard Extended Market ETF | 0.00% | $3M |
| IWOiShares Russell 2000 Growth ETF | 0.02% | $2M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $369K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AVXL Jan avg: -0.04% median: 1.85% win: 50% σ: 30.56% n: 4 2022-04-12 → 2026-05-29 | AVXL Feb avg: -11.68% median: -13.16% win: 0% σ: 4.07% n: 4 2022-04-12 → 2026-05-29 | AVXL Mar avg: -8.29% median: -5.48% win: 25% σ: 16.73% n: 4 2022-04-12 → 2026-05-29 | AVXL Apr avg: -7.60% median: -5.02% win: 40% σ: 18.13% n: 5 2022-04-12 → 2026-05-29 | AVXL May avg: 0.16% median: 6.05% win: 60% σ: 14.67% n: 5 2022-04-12 → 2026-05-29 | AVXL Jun avg: 6.06% median: 6.91% win: 75% σ: 14.31% n: 4 2022-04-12 → 2026-05-29 (current) | AVXL Jul avg: 21.89% median: 12.53% win: 100% σ: 27.83% n: 4 2022-04-12 → 2026-05-29 | AVXL Aug avg: -9.22% median: -8.97% win: 0% σ: 4.72% n: 4 2022-04-12 → 2026-05-29 | AVXL Sep avg: -5.70% median: -6.66% win: 25% σ: 10.18% n: 4 2022-04-12 → 2026-05-29 | AVXL Oct avg: 2.30% median: 3.05% win: 50% σ: 17.34% n: 4 2022-04-12 → 2026-05-29 | AVXL Nov avg: -1.84% median: 0.84% win: 50% σ: 45.23% n: 4 2022-04-12 → 2026-05-29 | AVXL Dec avg: 10.15% median: 9.26% win: 75% σ: 15.21% n: 4 2022-04-12 → 2026-05-29 |